IL-6 Inhibitor Induction in Coculture Of Bronchial Epithelial Cells and Eosinophils

IL-6 Inhibitor
Eosinophil infiltration of the mucosa is a feature of asthmatic airways. Their adhesion to bronchial epithelial cells has been proposed to lead to the generation of inflammation mediators which may contribute to asthma pathology. Bronchial epithelial cells (BEAS-2B cell line) and peripheral blood eosinophils were cultured alone or in combination and the production of an inflammatory cytokine, IL-6, was measured. IL-6 was produced principally by epithelial cells and the production was enhanced more than 10-fold in the presence of eosinophils. Significant augmentation of epithelial IL-6 production persisted even when eosinophils were fixed with paraformaldehyde. The eosinophil-induced IL-6 production was extensively inhibited by inhibitors of p38 mitogen-activated protein (MAP) kinase or nuclear factor ??B (NF??B). (more…)

Budesonide Inhalation Dose versus Maintenance Treatment in Asthma Exacerbations

budesonide inhalation
This study was similar to the study of Harrison and colleagues, which looked at doubling the dose of inhaled corticosteroid during an asthma exacerbation. This study investigated whether doubling the dose of budesonide inhalation in patients on regular inhaled budesonide would be beneficial during an asthma exacerbation. (more…)

Leukotriene B4 in Exhaled Breath Condensate And Sputum

Leukotriene B4
Some features seem to be common to severe asthma and Chronic Obstructive Pulmonary Disease with reversibility of airflow limitation. The neutrophil chemoattractant leukotriene B 4 (LTB 4) may play a role in Chronic Obstructive Pulmonary Disease and in some forms of asthma. In this study, 55 smokers with no disease, Chronic Obstructive Pulmonary Disease (with or without bronchodilator reversibility of airflow limitation) or asthma underwent measurement of LTB 4 in sputum supernatants and exhaled breath condensate asthma (EBC). Both Chronic Obstructive Pulmonary Disease and asthma patients had higher levels of LTB 4 than control subjects; patients with asthma or reversible Chronic Obstructive Pulmonary Disease exhibited significantly higher levels of LTB 4 than those with irreversible Chronic Obstructive Pulmonary Disease. (more…)

Mite Allergen-Impermeable Bed-Covering System Effectiveness In Asthmatic Mite-Sensitive Patients

Allergen exposure plays a role in the development of asthma bronchial hyper-responsiveness and in the acute inflammatory response seen in asthmatic patients. Reduction of house dust mite allergens might lead to better lung function and reduction of asthma symptoms. (more…)

Vascular Endothelial Growth Factor (VEGF) & Induces Muscle Hyperflasia Enhances TH2-Mediated Sensitization

Vascular Endothelial Growth Factor (VEGF), originally described as a vascular permeability factor generating tissue oedema, has been found to exert a range of angiogenic actions, including epithelial cell proliferation, blood vessel formation and endothelial cell survival. Elevated levels of Vascular Endothelial Growth Factor have been detected in bronchial tissues and secretions of asthmatic bronchial individuals, raising questions regarding its possible pathogenetic role in asthma. Using transgenic mice in which local over expression of VEGF could be induced in the lungs by administration of a tetracycline antibiotic demonstrated induction of an asthma-like phenotype with airway inflammation and oedema, hyper-responsiveness and remodelling (airway, parenchymal and vascular). Antigen-induced airway inflammation was accompanied by VEGF production by epithelial cells and TH2 cells, with production by Th1 cells markedly lower. (more…)

Asthma With Concomitant Allergic Rhinitis Among Asthmatic Children

Asthmatic children who also have Allergic Rhinitis seem to have higher morbidity and to use more healthcare resources. This was further investigated to determine the incremental effect of Allergic Rhinitis on healthcare resource use in children with asthma. The data were from a general practice database in the UK and covered the period 1998–2001. Children aged 6–15 years who had an asthma related visit to their general practitioner at least once during a defined 12 month period were reviewed. (more…)

Daily Versus As-Needed Corticosteroids For Mild Persistent Asthma

The guidelines for asthma management recommend the use of regular inhaled corticosteroid in patients with mild persistent asthma, but in clinical practice it has been observed that patients often do not feel the need to use their inhaled corticosteroid regularly, which may lead to poor compliance. One possible reason is that because there are no symptoms the patients are not reminded to use their medications. Hence, the use of intermittent inhaled corticosteroid during worsening of asthma may be an option that could be considered in these subgroups of asthmatics. (more…)

Use Of Exhaled Nitric Oxide Measurements To Guide Treatment In Chronic Asthma

Adjusting the inhaled glucocorticoid dose based on indices of airway inflammation has been proposed as a means of achieving more effective control of asthma than the conventional approach of adjusting steroid dose based on symptoms, lung function and rescue medication use. In a single-blind, placebo-controlled trial, 97 asthmatic patients received fluticasone doses adjusted on the basis either of conventional guidelines or of exhaled nitric oxide fraction (FE NO ). (more…)

Antigen-Specific Cd4 T Cells Drive Airways Smooth Muscle Remodeling In Experimental Asthma

Cd4 T Cells
Airway hyper-responsiveness in asthma may involve smooth muscle growth, a manifestation of airway remodelling. The involvement of inflammatory cells in the induction of airway smooth muscle growth was studied in vivo and ex vivo in a brown Norway rat model of asthma. Transfer of CD4 + T lymphocytes from ovalbuminsensitized animals induced an increase in airway smooth muscle mass in naive animals upon repeated ovalbumin challenge. Ex vivo, coculture of antigen-stimulated CD4 + T cells and airway smooth muscle cells led to myocyte proliferation and prolonged T-cell survival. (more…)

Allergic Rhinitis Asthma Symptoms and Syndrome

Allergic Rhinitis Asthma
Allergic rhinitis is a high-prevalence disease. This high prevalence translates into a high cost to society in terms of overall healthcare utilization, and also a high cost in terms of the quality of life of those who suffer from moderate or severe disease.

Allergic rhinitis has traditionally been divided into seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR). This classification is helpful in indicating the season of maximum symptoms and the likely causative allergens immunotherapy. (more…)

Next Page »